Denica Blazheva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Denica Blazheva has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandar Slavchev
Department of Microbiology and Biotechnology, University of Food Technologies, 26 Maritza Blvd., 4002 Plovdiv, Bulgaria
12 shared publications - Petja Marinova
Department of General and Inorganic Chemistry with Methodology of Chemistry Education, Faculty of Chemistry, University of Plovdiv, “Tzar Assen” Str. 24, 4000 Plovdiv, Bulgaria
12 shared publications - Mariya Brazkova
Department of Microbiology and biotechnology, University of Food Technologies, 26 Maritsa Blvd., 4002 Plovdiv, Bulgaria
10 shared publications - Galena Angelova
Department of Microbiology and biotechnology, University of Food Technologies, 26 Maritsa Blvd., 4002 Plovdiv, Bulgaria
8 shared publications - Nikola Burdzhiev
Department of Organic Chemistry and Pharmacognosy, Faculty of Chemistry and Pharmacy, University of Sofia, 1, J. Bourchier Av., 1164 Sofia, Bulgaria
7 shared publications - Bogdan Goranov
Department of Microbiology and Biotechnology, University of Food Technologies, 26 Maritza Boulevard, 4002 Plovdiv, Bulgaria
6 shared publications
Latest Publications
- Open Access
Design and Characterization of Cu(II), Ni(II), and Co(II) Complexes with 5-Carboxy-2-Thiouracil: Spectroscopic, Antimicrobial and Cytotoxic Studies
In this paper, we describe and verify the structures and biological activity of novel metal complexes derived from 5-carboxy-2-thiouracil. We outline a synthesis method and assess the antimicrobial activity of newly formed Cu(II), Ni(II) and Co(II) complexes. Several syntheses were carried out with and without NaOH. The structures were verified using melting point analysis, MP-AES for Cu, Ni and Co and ICP-OES for sulfur, UV-Vis, ATR, solid-state and solution 1H NMR, 13C NMR spectroscopy. In addition, the antimicrobial activity of these complexes and the free ligand were assessed against both Gram-positive and Gram-negative bacteria, as well as yeasts. The HCT-116 colorectal cell line (ATCC) was used for a cytotoxic assay. Only two Ni(II) complexes showed reduction in the number of viable tumor cells. None of the other compounds led to a significant reduction in the number of viable cells, as determined by one-way ANOVA statistical analysis.
Open AccessDesign and Characterization of Cu(II), Ni(II), and Co(II) Complexes with 5-Carboxy-2-Thiouracil: Spectroscopic, Antimicrobial and Cytotoxic Studies
In this paper, we describe and verify the structures and biological activity of novel metal complexes derived from 5-carboxy-2-thiouracil. We outline a synthesis method and assess the antimicrobial activity of newly formed Cu(II), Ni(II) and Co(II) complexes. Several syntheses were carried out with and without NaOH. The structures were verified using melting point analysis, MP-AES for Cu, Ni and Co and ICP-OES for sulfur, UV-Vis, ATR, solid-state and solution 1H NMR, 13C NMR spectroscopy. In addition, the antimicrobial activity of these complexes and the free ligand were assessed against both Gram-positive and Gram-negative bacteria, as well as yeasts. The HCT-116 colorectal cell line (ATCC) was used for a cytotoxic assay. Only two Ni(II) complexes showed reduction in the number of viable tumor cells. None of the other compounds led to a significant reduction in the number of viable cells, as determined by one-way ANOVA statistical analysis.
- Open Access
- 22 September 2026
- Published by MDPI AG in Preprints.org
Design and Characterization of Cu(II), Ni(II), and Co(II) Complexes with 5-Carboxy-2-Thiouracil: Spectroscopic, Antimicrobial and Cytotoxic Studies
The aim of this paper is to obtain and verify the structures and the biological activity of novel metal complexes derived from 5-carboxy-2-thiouracil. The paper outlines a synthesis method and assesses the antimicrobial activity of newly formed Cu(II), Ni(II) and Co(II) complexes. Several syntheses were carried out with and without NaOH. The structural were verified by melting point analysis, ICP-OES for Cu, Ni and Co, UV-Vis, ATR, solid state and solution 1H NMR, 13C NMR spectroscopy. In addition, the antimi-crobial activity of these complexes and the free ligand are assessed against both Gram-positive and Gram-negative bacteria, as well as yeasts. For the cytotoxic assay we were used the HCT-116 colorectal cell line (ATCC). Only two Ni(II) complexes show reduction in the number of viable tumor cells. All the other compounds did not lead to a significant reduction in the number of viable cells as determined by one-way ANOVA statistical analysis.
- 22 September 2026
- Published by MDPI AG in Preprints.org
Open AccessDesign and Characterization of Cu(II), Ni(II), and Co(II) Complexes with 5-Carboxy-2-Thiouracil: Spectroscopic, Antimicrobial and Cytotoxic Studies
The aim of this paper is to obtain and verify the structures and the biological activity of novel metal complexes derived from 5-carboxy-2-thiouracil. The paper outlines a synthesis method and assesses the antimicrobial activity of newly formed Cu(II), Ni(II) and Co(II) complexes. Several syntheses were carried out with and without NaOH. The structural were verified by melting point analysis, ICP-OES for Cu, Ni and Co, UV-Vis, ATR, solid state and solution 1H NMR, 13C NMR spectroscopy. In addition, the antimi-crobial activity of these complexes and the free ligand are assessed against both Gram-positive and Gram-negative bacteria, as well as yeasts. For the cytotoxic assay we were used the HCT-116 colorectal cell line (ATCC). Only two Ni(II) complexes show reduction in the number of viable tumor cells. All the other compounds did not lead to a significant reduction in the number of viable cells as determined by one-way ANOVA statistical analysis.
- Open Access
- 27 July 2026
- Published by MDPI AG in Inorganics
- Vol. 14 (8) , 200
A Recent Review of the Therapeutic Potential of Gold, Platinum, and Ruthenium Complexes Combined with Certain Organic Compounds
The synthesis and systematic investigation of inorganic and organic compounds are fundamental to medicinal and pharmaceutical chemistry, particularly for developing novel therapeutic agents. Transition-metal complexes and bioactive organic compounds have shown significant potential to modulate cellular pathways, yielding anticancer, antimicrobial, and anti-inflammatory effects. This review summarizes recent advances in the synthesis, structural characterization, and therapeutic evaluation of gold (Au), platinum (Pt), and ruthenium (Ru) complexes, as well as selected organic compounds, with an emphasis on their biological activities and potential clinical relevance. The integration of synthetic chemistry with biological evaluation underscores the therapeutic potential of gold (Au), platinum (Pt), and ruthenium (Ru) complexes, as well as organic compounds. Au(I/III), Pt(II/IV), and Ru(II/III) complexes demonstrated notable in vivo anticancer activity, while selected organic derivatives exhibited promising bioactive properties. This review aims to support researchers and clinicians in the ongoing development of novel compounds with clinical relevance for anticancer, antimicrobial, and anti-inflammatory applications.
- 27 July 2026
- Published by MDPI AG in Inorganics
- Vol. 14 (8) , 200
Open AccessA Recent Review of the Therapeutic Potential of Gold, Platinum, and Ruthenium Complexes Combined with Certain Organic Compounds
The synthesis and systematic investigation of inorganic and organic compounds are fundamental to medicinal and pharmaceutical chemistry, particularly for developing novel therapeutic agents. Transition-metal complexes and bioactive organic compounds have shown significant potential to modulate cellular pathways, yielding anticancer, antimicrobial, and anti-inflammatory effects. This review summarizes recent advances in the synthesis, structural characterization, and therapeutic evaluation of gold (Au), platinum (Pt), and ruthenium (Ru) complexes, as well as selected organic compounds, with an emphasis on their biological activities and potential clinical relevance. The integration of synthetic chemistry with biological evaluation underscores the therapeutic potential of gold (Au), platinum (Pt), and ruthenium (Ru) complexes, as well as organic compounds. Au(I/III), Pt(II/IV), and Ru(II/III) complexes demonstrated notable in vivo anticancer activity, while selected organic derivatives exhibited promising bioactive properties. This review aims to support researchers and clinicians in the ongoing development of novel compounds with clinical relevance for anticancer, antimicrobial, and anti-inflammatory applications.
- Open Access
- 1 March 2026
- Published by MDPI AG in Journal of Fungi
- Vol. 12 (3) , 177
In Vitro Modeling of Mycelium Biomass Growth Kinetics of the Novel Fungicolous Species Xylaria karsticola NBIMCC 9097, with Insights into Its Antimicrobial Potential
Xylaria karsticola NBIMCC 9097 is a recently described and rare fungicolous species originating from Bulgaria. Understanding its growth behavior and bioactive potential is essential for evaluating its biotechnological and pharmaceutical relevance. In the presented study, we model the in vitro growth kinetics of X. karsticola mycelium under submerged cultivation and assess its antimicrobial activity. Optimization of MCM and MYB media markedly increased biomass yields to 20.11 and 23.25 g/dm3, respectively, compared with non-optimized media (9.9 ± 0.21 and 10.8 ± 0.28 g/dm3). The maximum specific growth rate was higher in the MCM (0.803 ± 0.004 h−1) in comparison with the MYB medium (0.711 ± 0.003 h−1); however, the MYB medium supported greater biomass accumulation and more efficient substrate utilization, reflected by a higher utilization coefficient (0.9900 ± 0.001 versus 0.9644 ± 0.005). The antimicrobial activity was evaluated using agar disk diffusion and minimum inhibitory concentration assays against Gram-positive and Gram-negative bacteria and yeasts. Hexane and ethyl acetate extracts were most effective against Pseudomonas aeruginosa ATCC 9027 (MIC 0.067 and 0.059 mg/cm3), while notable anti-yeast activity was observed, particularly against Wickerhamomyces anomalus, Saccharomycodes ludwigii, and Pichia membranifaciens. The lowest MIC (0.02 mg/cm3) was recorded for the water biomass extract against S. ludwigii indicating potent antimicrobial activity against the tested microorganism. These findings identify X. karsticola as a potential source of antimicrobial metabolites and provide a strong motivation for comprehensive metabolomic profiling and systematic optimization of its cultivation.
- 1 March 2026
- Published by MDPI AG in Journal of Fungi
- Vol. 12 (3) , 177
Open AccessIn Vitro Modeling of Mycelium Biomass Growth Kinetics of the Novel Fungicolous Species Xylaria karsticola NBIMCC 9097, with Insights into Its Antimicrobial Potential
Xylaria karsticola NBIMCC 9097 is a recently described and rare fungicolous species originating from Bulgaria. Understanding its growth behavior and bioactive potential is essential for evaluating its biotechnological and pharmaceutical relevance. In the presented study, we model the in vitro growth kinetics of X. karsticola mycelium under submerged cultivation and assess its antimicrobial activity. Optimization of MCM and MYB media markedly increased biomass yields to 20.11 and 23.25 g/dm3, respectively, compared with non-optimized media (9.9 ± 0.21 and 10.8 ± 0.28 g/dm3). The maximum specific growth rate was higher in the MCM (0.803 ± 0.004 h−1) in comparison with the MYB medium (0.711 ± 0.003 h−1); however, the MYB medium supported greater biomass accumulation and more efficient substrate utilization, reflected by a higher utilization coefficient (0.9900 ± 0.001 versus 0.9644 ± 0.005). The antimicrobial activity was evaluated using agar disk diffusion and minimum inhibitory concentration assays against Gram-positive and Gram-negative bacteria and yeasts. Hexane and ethyl acetate extracts were most effective against Pseudomonas aeruginosa ATCC 9027 (MIC 0.067 and 0.059 mg/cm3), while notable anti-yeast activity was observed, particularly against Wickerhamomyces anomalus, Saccharomycodes ludwigii, and Pichia membranifaciens. The lowest MIC (0.02 mg/cm3) was recorded for the water biomass extract against S. ludwigii indicating potent antimicrobial activity against the tested microorganism. These findings identify X. karsticola as a potential source of antimicrobial metabolites and provide a strong motivation for comprehensive metabolomic profiling and systematic optimization of its cultivation.
- Open Access
- 21 January 2026
- Published by MDPI AG in Applied Sciences
- Vol. 16 (2) , 1114
Anticancer Applications of Gold Complexes: Structure–Activity Review
Background: Gold (Au) complexes have emerged as promising anticancer candidates due to their distinct coordination chemistry and ability to modulate thiol-dependent and redox-regulated cellular pathways, particularly thioredoxin reductase (TrxR). In recent years, structurally diverse Au(I) and Au(III) complexes have been reported with potent in vitro anticancer activity; however, cross-study comparability and design principles remain unclear. Aim: This systematic review critically evaluates anticancer Au(I/III) complexes reported since 2016, with the specific aim of identifying how oxidation state, coordination geometry, and ligand class influence in vitro potency, selectivity, and translational potential. Methods: A PRISMA-guided literature search was performed in Scopus, Web of Science, PubMed, and ScienceDirect for studies published between January 2016 and March 2025. Two independent reviewers screened titles/abstracts and full texts according to predefined inclusion criteria. Only original studies reporting anticancer activity of structurally characterized Au(I/III) complexes in human cancer models were included. After the removal of duplicates, 1100 records were screened at the title and abstract level. Of these, 240 articles were assessed in full text for eligibility. Ultimately, 128 studies reporting anticancer activity of structurally characterized Au(I/III) complexes met the inclusion criteria and were included in the qualitative synthesis. Biological potency data were harmonized to μM units where applicable, and results were synthesized qualitatively due to heterogeneity in experimental design. Results: A total of 128 studies met the inclusion criteria. Au(I) complexes—particularly phosphine- and N-heterocyclic carbene (NHC)-based compounds—consistently showed sub-micromolar cytotoxicity in TrxR-dependent cancer cell lines, whereas Au(III) complexes displayed greater structural diversity but variable stability and redox behavior. In vivo efficacy was reported for a limited subset of compounds and was frequently constrained by solubility, systemic toxicity, or metabolic instability. Conclusions: The available evidence indicates that anticancer activity of gold complexes is strongly dependent on oxidation state, ligand environment, and redox stability. While Au(I) scaffolds show more reproducible in vitro potency, successful translation to in vivo models remains limited. This review defines structure–activity and structure–liability relationships that can guide the rational design of next-generation gold-based anticancer agents.
- 21 January 2026
- Published by MDPI AG in Applied Sciences
- Vol. 16 (2) , 1114
Open AccessAnticancer Applications of Gold Complexes: Structure–Activity Review
Background: Gold (Au) complexes have emerged as promising anticancer candidates due to their distinct coordination chemistry and ability to modulate thiol-dependent and redox-regulated cellular pathways, particularly thioredoxin reductase (TrxR). In recent years, structurally diverse Au(I) and Au(III) complexes have been reported with potent in vitro anticancer activity; however, cross-study comparability and design principles remain unclear. Aim: This systematic review critically evaluates anticancer Au(I/III) complexes reported since 2016, with the specific aim of identifying how oxidation state, coordination geometry, and ligand class influence in vitro potency, selectivity, and translational potential. Methods: A PRISMA-guided literature search was performed in Scopus, Web of Science, PubMed, and ScienceDirect for studies published between January 2016 and March 2025. Two independent reviewers screened titles/abstracts and full texts according to predefined inclusion criteria. Only original studies reporting anticancer activity of structurally characterized Au(I/III) complexes in human cancer models were included. After the removal of duplicates, 1100 records were screened at the title and abstract level. Of these, 240 articles were assessed in full text for eligibility. Ultimately, 128 studies reporting anticancer activity of structurally characterized Au(I/III) complexes met the inclusion criteria and were included in the qualitative synthesis. Biological potency data were harmonized to μM units where applicable, and results were synthesized qualitatively due to heterogeneity in experimental design. Results: A total of 128 studies met the inclusion criteria. Au(I) complexes—particularly phosphine- and N-heterocyclic carbene (NHC)-based compounds—consistently showed sub-micromolar cytotoxicity in TrxR-dependent cancer cell lines, whereas Au(III) complexes displayed greater structural diversity but variable stability and redox behavior. In vivo efficacy was reported for a limited subset of compounds and was frequently constrained by solubility, systemic toxicity, or metabolic instability. Conclusions: The available evidence indicates that anticancer activity of gold complexes is strongly dependent on oxidation state, ligand environment, and redox stability. While Au(I) scaffolds show more reproducible in vitro potency, successful translation to in vivo models remains limited. This review defines structure–activity and structure–liability relationships that can guide the rational design of next-generation gold-based anticancer agents.
- Open Access
- 15 October 2025
- Published by MDPI AG in Preprints.org
A Comprehensive Review of the Synthesis, Characterization, and Therapeutic Potential of Gold, Platinum, and Ruthenium Complexes and Organic Compounds
The synthesis and systematic investigation of inorganic and organic compounds represent a crucial area in medicinal and pharmaceutical chemistry, particularly in the pursuit of novel therapeutic agents. This study reports on the preparation, structural analysis, and evaluation of selected inorganic and organic compounds with emphasis on their physicochemical characteristics and biological activities. Both categories of compounds were examined for their potential therapeutic relevance, including anticancer, antimicrobial, and anti-inflammatory properties. Inorganic complexes, particularly those incorporating transition metals, demonstrated promising activity that may be attributed to their ability to interact with bimolecular targets and modulate cellular pathways. Similarly, organic derivatives revealed bioactive features that merit further exploration. Collectively, the results underscore the therapeutic potential of synthesized compounds and contribute to the growing field of drug design involving both inorganic and organic frameworks. This work emphasizes the integration of synthetic chemistry, as well as natural products with biological evaluation as a pathway toward identifying effective molecules with clinical relevance. Here, we highlighted some of the most recently developed Au(I/III), Pt(II/IV) and Ru(II/III) complexes that have shown significant in vivo antitumor properties between 2016 and 2025, as well as the antimicrobial and anti-inflammatory properties of different inorganic and organic compounds. Our review emphasizes on gold, platinum and ruthenium complexes synthesis and characterizations of inorganic and organic compounds with biomedical potential. The main focus is on the antitumor effects reported in 89 articles of inorganic and organic compounds, 53 on antimicrobial action and 17 on anti-inflammatory activities. In our review we cover the synthesis (30 articles) and characterizations (30 papers) of inorganic and organic compounds with potential biological and therapeutic effects. It is anticipated that this review will serve as a valuable resource in the future, particularly for professionals engaged in clinical, medical, and health-related disciplines.
- 15 October 2025
- Published by MDPI AG in Preprints.org
Open AccessA Comprehensive Review of the Synthesis, Characterization, and Therapeutic Potential of Gold, Platinum, and Ruthenium Complexes and Organic Compounds
The synthesis and systematic investigation of inorganic and organic compounds represent a crucial area in medicinal and pharmaceutical chemistry, particularly in the pursuit of novel therapeutic agents. This study reports on the preparation, structural analysis, and evaluation of selected inorganic and organic compounds with emphasis on their physicochemical characteristics and biological activities. Both categories of compounds were examined for their potential therapeutic relevance, including anticancer, antimicrobial, and anti-inflammatory properties. Inorganic complexes, particularly those incorporating transition metals, demonstrated promising activity that may be attributed to their ability to interact with bimolecular targets and modulate cellular pathways. Similarly, organic derivatives revealed bioactive features that merit further exploration. Collectively, the results underscore the therapeutic potential of synthesized compounds and contribute to the growing field of drug design involving both inorganic and organic frameworks. This work emphasizes the integration of synthetic chemistry, as well as natural products with biological evaluation as a pathway toward identifying effective molecules with clinical relevance. Here, we highlighted some of the most recently developed Au(I/III), Pt(II/IV) and Ru(II/III) complexes that have shown significant in vivo antitumor properties between 2016 and 2025, as well as the antimicrobial and anti-inflammatory properties of different inorganic and organic compounds. Our review emphasizes on gold, platinum and ruthenium complexes synthesis and characterizations of inorganic and organic compounds with biomedical potential. The main focus is on the antitumor effects reported in 89 articles of inorganic and organic compounds, 53 on antimicrobial action and 17 on anti-inflammatory activities. In our review we cover the synthesis (30 articles) and characterizations (30 papers) of inorganic and organic compounds with potential biological and therapeutic effects. It is anticipated that this review will serve as a valuable resource in the future, particularly for professionals engaged in clinical, medical, and health-related disciplines.
- Open Access
- 10 October 2025
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (10) , 727
Molecular Identification, Mycelial Growth Kinetics, and Antimicrobial Potential of Newly Isolated Medicinal Mushroom Fomitopsis pinicola from Bulgaria
The present study is focused on a newly isolated Fomitopsis strain obtained from black pine (Pinus nigra) from the Sredna Gora Mountains, Bulgaria. Molecular identification, based on ITS1-5.8S-ITS2 region sequencing, confirmed the strain as Fomitopsis pinicola with 99.84 BLAST percent identity. Phylogenetic analysis verified that the new fungal isolate belongs to the European F. pinicola clade. The morphological analysis of the strain revealed several distinctive structures that further support its identification. The influence of culture media composition on fungal development was evaluated by analyzing the mycelial growth kinetics using both the logistic growth model and the reversible autocatalytic model. Submerged cultivation was employed to produce fungal biomass, which was subsequently lyophilized and used for the assessment of the antimicrobial potential of the fungal strain. The results demonstrated notable antimicrobial effects against all tested bacterial strains. The most significant activity was observed for the aqueous extract against Escherichia coli and the hexane extract against Salmonella enteritidis, both with a minimum inhibitory concentration of 312.5 µg/mL. These findings highlight the promising potential of the newly isolated F. pinicola strain for future applications in the medical and pharmaceutical industries, particularly in developing drugs to combat multidrug resistance, based on the promising results of its water extracts.
- 10 October 2025
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (10) , 727
Open AccessMolecular Identification, Mycelial Growth Kinetics, and Antimicrobial Potential of Newly Isolated Medicinal Mushroom Fomitopsis pinicola from Bulgaria
The present study is focused on a newly isolated Fomitopsis strain obtained from black pine (Pinus nigra) from the Sredna Gora Mountains, Bulgaria. Molecular identification, based on ITS1-5.8S-ITS2 region sequencing, confirmed the strain as Fomitopsis pinicola with 99.84 BLAST percent identity. Phylogenetic analysis verified that the new fungal isolate belongs to the European F. pinicola clade. The morphological analysis of the strain revealed several distinctive structures that further support its identification. The influence of culture media composition on fungal development was evaluated by analyzing the mycelial growth kinetics using both the logistic growth model and the reversible autocatalytic model. Submerged cultivation was employed to produce fungal biomass, which was subsequently lyophilized and used for the assessment of the antimicrobial potential of the fungal strain. The results demonstrated notable antimicrobial effects against all tested bacterial strains. The most significant activity was observed for the aqueous extract against Escherichia coli and the hexane extract against Salmonella enteritidis, both with a minimum inhibitory concentration of 312.5 µg/mL. These findings highlight the promising potential of the newly isolated F. pinicola strain for future applications in the medical and pharmaceutical industries, particularly in developing drugs to combat multidrug resistance, based on the promising results of its water extracts.
- Open Access
- 30 September 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (19) , 10571
Agro-Industrial Residues as Cost-Effective and Sustainable Substrates for the Cultivation of Epicoccum nigrum, with Insights into Growth Kinetic Characteristics and Biological Activities
A significant quantity of agro-industrial waste is generated globally across various agricultural sectors and food industries. Composed primarily of cellulose, hemicellulose, and lignin—known as lignocellulosic materials—this waste holds significant potential and can be repurposed as a nutrient-rich substrate for mushroom cultivation. Therefore, mushroom cultivation can be regarded as a promising biotechnological approach for the reduction and valorization of agro-industrial waste. This investigation is the first to explore the utilization of agro-industrial waste- and by-products for the cultivation of Epicoccum nigrum for the production of extracts with valuable biological activities. The logistic curve and autocatalytic growth models were applied to study the kinetics of the growth process on wheat bran, sunflower cake, wheat straw, pine sawdust, and steam-distilled lavender straw substrates. Through mathematical modeling, the optimal composition of a nutrient medium containing the selected substrates was determined and successfully validated in experimental conditions. Biologically active water extracts were obtained after solid-state cultivation with α-amylase and cellulase activity up to 10.6 ± 0.6 U/mL and 0.52 ± 0.03 U/g, respectively. The extracts exhibited antimicrobial activity against fungal strains from six different species, and the most susceptible was the phytopathogen Sclerotinia sclerotiorum, with a minimum inhibitory concentration of 0.156–0.313 mg/mL.
- 30 September 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (19) , 10571
Open AccessAgro-Industrial Residues as Cost-Effective and Sustainable Substrates for the Cultivation of Epicoccum nigrum, with Insights into Growth Kinetic Characteristics and Biological Activities
A significant quantity of agro-industrial waste is generated globally across various agricultural sectors and food industries. Composed primarily of cellulose, hemicellulose, and lignin—known as lignocellulosic materials—this waste holds significant potential and can be repurposed as a nutrient-rich substrate for mushroom cultivation. Therefore, mushroom cultivation can be regarded as a promising biotechnological approach for the reduction and valorization of agro-industrial waste. This investigation is the first to explore the utilization of agro-industrial waste- and by-products for the cultivation of Epicoccum nigrum for the production of extracts with valuable biological activities. The logistic curve and autocatalytic growth models were applied to study the kinetics of the growth process on wheat bran, sunflower cake, wheat straw, pine sawdust, and steam-distilled lavender straw substrates. Through mathematical modeling, the optimal composition of a nutrient medium containing the selected substrates was determined and successfully validated in experimental conditions. Biologically active water extracts were obtained after solid-state cultivation with α-amylase and cellulase activity up to 10.6 ± 0.6 U/mL and 0.52 ± 0.03 U/g, respectively. The extracts exhibited antimicrobial activity against fungal strains from six different species, and the most susceptible was the phytopathogen Sclerotinia sclerotiorum, with a minimum inhibitory concentration of 0.156–0.313 mg/mL.
- Open Access
Investigation of the Cytotoxicity of Cu(II), Au(III), and Pd(II) Complexes with 2,4-Dithiouracil and 6-Propyl-2-thiouracil Derivatives
This study investigates the cytotoxic properties of metal complexes incorporating thio-uracil derivatives, specifically 2,4-dithiouracil and 6-propyl-2-thiouracil. The research focuses on the cytotoxic effects of Cu(II) and Pd(II) complexes with 6-propyl-2-thiouracil, as well as mixed-ligand transition metal Cu(II) and Au(III) complexes of 2,4-dithiouracil with 2-thiouracil and uracil. Cytotoxic activity was assessed against human cervical carcinoma cells (HeLa) and normal kidney cells from the African green monkey. The results demonstrated that incorporating Cu(II) and Au(III) into the compound structures significantly enhanced their cytotoxic effects. Notably, all tested complexes exhibited a stronger inhibitory effect on cancer cell proliferation compared to normal cells, with the palladium(II) complex of 6-propyl-2-thiouracil showing the lowest CD50 value against the tumor cell line (0.00064 mM), which were 149 times lower than that of the ligand (0.0955 mM). These findings suggest that thio-uracil-based metal complexes, particularly those containing palladium (II) and gold(III), hold significant potential for further development as anticancer agents.
Open AccessInvestigation of the Cytotoxicity of Cu(II), Au(III), and Pd(II) Complexes with 2,4-Dithiouracil and 6-Propyl-2-thiouracil Derivatives
This study investigates the cytotoxic properties of metal complexes incorporating thio-uracil derivatives, specifically 2,4-dithiouracil and 6-propyl-2-thiouracil. The research focuses on the cytotoxic effects of Cu(II) and Pd(II) complexes with 6-propyl-2-thiouracil, as well as mixed-ligand transition metal Cu(II) and Au(III) complexes of 2,4-dithiouracil with 2-thiouracil and uracil. Cytotoxic activity was assessed against human cervical carcinoma cells (HeLa) and normal kidney cells from the African green monkey. The results demonstrated that incorporating Cu(II) and Au(III) into the compound structures significantly enhanced their cytotoxic effects. Notably, all tested complexes exhibited a stronger inhibitory effect on cancer cell proliferation compared to normal cells, with the palladium(II) complex of 6-propyl-2-thiouracil showing the lowest CD50 value against the tumor cell line (0.00064 mM), which were 149 times lower than that of the ligand (0.0955 mM). These findings suggest that thio-uracil-based metal complexes, particularly those containing palladium (II) and gold(III), hold significant potential for further development as anticancer agents.
- Open Access
- 8 May 2025
- Published by MDPI AG in Preprints.org
Investigation of the Cytotoxicity of Metal Complexes with Thiouracil Derivatives
This study investigates the cytotoxic properties of metal complexes incorporating thio-uracil de-rivatives, specifically 2,4-dithiouracil and 6-propyl-2-thiouracil. The research focuses on the cyto-toxic effects of Cu(II) and Pd(II) complexes with 6-propyl-2-thiouracil, as well as mixed-ligand transition metal Cu(II) and Au(III) complexes of 2,4-dithiouracil with 2-thiouracil and uracil. Cy-totoxic activity was assessed against human cervical carcinoma cells (HeLa) and normal kidney cells from the African green monkey. The results demonstrated that incorporating Cu(II) and Au(III) into the compound structures significantly enhanced their cytotoxic effects. Notably, all tested complexes exhibited a stronger inhibitory effect on cancer cell proliferation compared to normal cells, with the gold(III) complex of 6-propyl-2-thiouracil showing the lowest CD50 value against the tumor cell line. These findings suggest that thio-uracil-based metal complexes, partic-ularly those containing gold(III), hold significant potential for further development as anticancer agents.
- 8 May 2025
- Published by MDPI AG in Preprints.org
Open AccessInvestigation of the Cytotoxicity of Metal Complexes with Thiouracil Derivatives
This study investigates the cytotoxic properties of metal complexes incorporating thio-uracil de-rivatives, specifically 2,4-dithiouracil and 6-propyl-2-thiouracil. The research focuses on the cyto-toxic effects of Cu(II) and Pd(II) complexes with 6-propyl-2-thiouracil, as well as mixed-ligand transition metal Cu(II) and Au(III) complexes of 2,4-dithiouracil with 2-thiouracil and uracil. Cy-totoxic activity was assessed against human cervical carcinoma cells (HeLa) and normal kidney cells from the African green monkey. The results demonstrated that incorporating Cu(II) and Au(III) into the compound structures significantly enhanced their cytotoxic effects. Notably, all tested complexes exhibited a stronger inhibitory effect on cancer cell proliferation compared to normal cells, with the gold(III) complex of 6-propyl-2-thiouracil showing the lowest CD50 value against the tumor cell line. These findings suggest that thio-uracil-based metal complexes, partic-ularly those containing gold(III), hold significant potential for further development as anticancer agents.